指南与共识胃肠动力与功能性疾病消化内镜

新型阻抗-pH参数与PPI反应相关:Lyon共识下不确定GERD诊断患者的解读

Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
指南 / 共识 · Aliment Pharmacol Ther · 2021-06-28

该研究回顾性分析233例典型反流症状患者的阻抗-pH轨迹,其中65例按Lyon共识为不确定GERD诊断。结果显示,该组中PPI应答者异常MNBI或PSPW index的比例显著高于非应答者,多因素分析证实病理PSPW index和/或MNBI值与PPI应答显著相关。

要点

  • 不确定GERD诊断患者中,异常MNBI或PSPW index更常见于PPI应答者。
  • 病理PSPW index和/或MNBI值与PPI应答显著相关。
  • MNBI与PSPW index可作为辅助指标识别可能对PPI应答的患者。

核心结论

  • MNBI和PSPW index可作为辅助指标,用于表征不确定GERD诊断患者并识别对PPI治疗应答者。

研究设计与样本

  • 回顾性分析PPI应答者和非应答者的阻抗-pH轨迹,共纳入233例有典型反流症状的患者。

主要发现

  • 145/233(62.2%)为PPI应答者;62例有GERD确诊证据,65例为不确定诊断,46例为反流高敏感,60例为功能性烧心。
  • 不确定GERD组中异常MNBI和PSPW index的发生率显著高于功能性烧心组(P < 0.001)。
  • 不确定GERD组内,35/65(54%)为PPI应答者,其病理MNBI或PSPW index比例显著高于非应答者(32/35 [91.4%]和30/35 [85.7%] vs 9/30 [30%]和7/30 [23.3%],P < 0.001)。
  • 多因素分析显示,病理PSPW index和/或MNBI值与所有组的PPI应答显著相关。

临床怎么用

  • 对Lyon共识下不确定GERD诊断的患者,可结合MNBI和PSPW index辅助判断PPI应答可能性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Lyon Consensus delineates impedance-pH parameters that can demonstrate/exclude gastro-oesophageal reflux disease (GERD). In patients with acid exposure time between 4% and 6%, GERD diagnosis has been considered inconclusive. In these cases, mean nocturnal baseline impedance (MNBI) and post-reflux swallow-induced peristaltic wave (PSPW) index may either confirm or refute GERD diagnosis and represent predictors of proton pump inhibitor (PPI) response. AIMS: To investigate the diagnostic yield of MNBI and PSPW index and their relationship with PPI response in patients with inconclusive GERD diagnosis. METHODS: Review of impedance-pH tracings from PPI responder/non-responder patients with typical reflux symptoms. Multivariate regression analysis was performed to determine the association of MNBI and PSPW index to PPI response. RESULTS: Among 233 patients evaluated, 145/233 (62.2%) were PPI responders; 62 had conclusive and 65 inconclusive evidence of GERD, 46 had reflux hypersensitivity, and 60 functional heartburn. Abnormal MNBI and PSPW index were significantly more frequent in inconclusive GERD as compared to the functional heartburn group (P < 0.001). Within the inconclusive GERD group, 35/65 (54%) patients were PPI responders and displayed a significantly higher proportion of cases with pathological MNBI or PSPW index as compared to non-responders (32/35 [91.4%] and 30/35 [85.7%] vs 9/30 [30%] and 7/30 [23.3%], P < 0.001). By multivariate analysis, pathological PSPW index and/or MNBI values were significantly associated with PPI response in all groups. CONCLUSIONS: The present study highlights the value of MNBI and PSPW index as adjunctive metrics in characterising patients with inconclusive evidence of GERD and identifying those responsive to PPI treatment.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Ribolsi M, Frazzoni M, Marabotto E, et al. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus. Aliment Pharmacol Ther. 2021. PMID: 34181753. doi:10.1111/apt.16481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。